Funding toward a cure
Tampa Bay Times – April 14
Over the last 30 years, Moffitt has made lasting contributions to the prevention and cure of cancer that have helped thousands in our community and beyond. As the cancer center looks toward its future, it has unveiled a major renovation and expansion project.—Richard Gonzmart
Locke Details Exciting Results for CAR T Cell Therapy in NHL
Targeted Oncology - April 13
The results of this clinical trial are really exciting to us,” said lead study author Frederick L. Locke, MD. “We have seen that 82% of patients can have a response to this single infusion; 54% of patients can have a CR, and 44% of patients are in an ongoing response at the time of the data cutoff.
Hurn: Get checked for prostate cancer
Tallahassee Democrat – April 13
The medical experts at Moffitt Cancer Center in Tampa and our own state-of-the-art Tallahassee Memorial Cancer Center developed a treatment plan, and I started chemotherapy on Sept. 30.
Lead ZUMA-1 Researcher Highlights CAR T Cell Findings in NHL
OncLive – April 12
In an interview with OncLive during the AACR meeting, Locke, a medical oncologist at Moffitt Cancer Center, discussed the ZUMA-1 trial and the next steps going forward.
Mount Sinai imaging symposium highlights latest research
Healthcare Business – April 12
Dr. Robert Gillies, chair of the Department of Cancer Imaging and Metabolism at the Moffitt Cancer Center, shared his research at the annual symposium hosted by the Translational and Molecular Imaging Institute (TMII) at the Icahn School of Medicine at Mount Sinai
Grateful for Moffitt Cancer Center
Orlando Sentinel – April 12
I was fortunate to connect with Dr. Fred Locke, who was spearheading a revolutionary immunotherapy trial at Moffitt Cancer Center in Tampa. I had zero chance of surviving my cancer before, but the CAR T trial gave me a 40 percent chance. Thankfully, I am lucky enough to be in that 40 percent.
Woman suffers collapsed lung from secondhand smoke
WTSP – April 12
Places like Moffitt Cancer Center offer Lung Cancer Screenings. Martinasek says getting tested is the best way to have peace of mind.
Local woman with rare cancer linked to breast implants
WFTS – April 11
“It’s very rare but women who have implants have an 18 fold or higher chance for this type of lymphoma,” days Dr. Frederick Locke. Also seen on WFLX and WRTV.
Conquer Cancer Foundation Honors 65 Young Oncology Professionals With Merit Awards
ASCO Post – April 10
Todd Cory Knepper, PharmD
H. Lee Moffitt Cancer Center & Research Institute
Pan-cancer Opportunities for Off-Label Immunotherapy Based on Nonsynonymous Mutation Burden (Abstract 14)
Transplant for Chronic Myeloid Leukemia
OncLive – April 10
Insights From: Kendra Sweet, MD, Moffitt Cancer Center; Naval Daver, MD, University of Texas MD Anderson Cancer Center; Javier Pinilla-Ibarz, MD, PhD, Moffitt Cancer Center
CAR T-Cell Therapy Yields High Response Rate in Aggressive Lymphoma
Cancer Network – April 7
In this video, Frederick Locke, MD, of the Moffitt Cancer Center in Tampa, Florida, discusses results of the ZUMA-1 trial, which tested chimeric antigen receptor (CAR) T-cell therapy with axicabtagene ciloleucel (axi-cel; KTE-C19) in this patient population.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.